José Manuel
Muñoz Félix
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (1)
2019
-
Novel Pure αvβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations
ACS Pharmacology and Translational Science, Vol. 2, Núm. 6, pp. 387-401